BACKGROUND: To evaluate potential sex differences, this study aimed to investigate blood pressure and lipid control and other risk factors for cardiovascular disease in treated hypertensive (tHT) patients from primary healthcare. DESIGN AND METHODS: This cross-sectional survey of tHT patients was carried out between 2002 and 2005 by 264 primary care physicians from Sweden who consecutively recruited 6537 tHT patients (48% men and 52% women) from medical records. RESULTS: tHT men more often reached the treatment goal for systolic/diastolic blood pressure, less than 140/90 mmHg, than tHT women (30 vs. 26%, P/=5.0 mmol/l than corresponding men (75 vs. 64% P<0.001). Men more often had diabetes (25 vs. 20% P<0.001), left ventricular hypertrophy ...
BACKGROUND: Diabetes is a stronger risk factor for cardiovascular complications in women than men.AI...
Background: In developing countries, gender-based treatment disparities in cardiovascular preventive...
OBJECTIVE: To summarize all available literature on sex differences in the pharmacological treatment...
The overall aim was to investigate the risk-factor profile in patients with hypertension, and patien...
International audienceThe objective of our study was to investigate differences in the management of...
International audienceThe objective of our study was to investigate differences in the management of...
In European countries and in the USA, hypertension represents an important risk factor for cardiovas...
SummaryBackgroundSeveral studies have shown gender differences in the management of cardiovascular r...
differences in risk factor control of treated hypertensives: a national primary healthcare-based stu...
OBJECTIVE: To describe and explain sex differences in antihypertensive drug use. DESIGN AND METHODS:...
BACKGROUND: Diabetes is a stronger risk factor for cardiovascular complications in women than men. A...
BACKGROUND: Diabetes is a stronger risk factor for cardiovascular complications in women than men. A...
BACKGROUND: Diabetes is a stronger risk factor for cardiovascular complications in women than men.AI...
BACKGROUND: Diabetes is a stronger risk factor for cardiovascular complications in women than men. A...
BACKGROUND: Diabetes is a stronger risk factor for cardiovascular complications in women than men.AI...
BACKGROUND: Diabetes is a stronger risk factor for cardiovascular complications in women than men.AI...
Background: In developing countries, gender-based treatment disparities in cardiovascular preventive...
OBJECTIVE: To summarize all available literature on sex differences in the pharmacological treatment...
The overall aim was to investigate the risk-factor profile in patients with hypertension, and patien...
International audienceThe objective of our study was to investigate differences in the management of...
International audienceThe objective of our study was to investigate differences in the management of...
In European countries and in the USA, hypertension represents an important risk factor for cardiovas...
SummaryBackgroundSeveral studies have shown gender differences in the management of cardiovascular r...
differences in risk factor control of treated hypertensives: a national primary healthcare-based stu...
OBJECTIVE: To describe and explain sex differences in antihypertensive drug use. DESIGN AND METHODS:...
BACKGROUND: Diabetes is a stronger risk factor for cardiovascular complications in women than men. A...
BACKGROUND: Diabetes is a stronger risk factor for cardiovascular complications in women than men. A...
BACKGROUND: Diabetes is a stronger risk factor for cardiovascular complications in women than men.AI...
BACKGROUND: Diabetes is a stronger risk factor for cardiovascular complications in women than men. A...
BACKGROUND: Diabetes is a stronger risk factor for cardiovascular complications in women than men.AI...
BACKGROUND: Diabetes is a stronger risk factor for cardiovascular complications in women than men.AI...
Background: In developing countries, gender-based treatment disparities in cardiovascular preventive...
OBJECTIVE: To summarize all available literature on sex differences in the pharmacological treatment...